The Hindu·3 min read·medium
Menarini Asia-Pacific and Pharmacosmos partner to bring first-in-class oncology supportive care therapy Cosela® to Asian patients
C
cuelive
✦AI Summary
Menarini Asia-Pacific has partnered with Pharmacosmos to distribute Cosela, a first-in-class therapy designed to protect bone marrow during chemotherapy. The agreement covers multiple Asian markets and aims to address unmet needs in oncology supportive care.
SINGAPORE , July 21, 2026 /PRNewswire/ -- Menarini Asia-Pacific today announced an exclusive partnership with Pharmacosmos A/S to register, commercialise and distribute Cosela ® (trilaciclib) across its Asia-Pacific markets.
healthbusiness
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in